{"version":"1.0","provider_name":"Allphase Pharma Consulting, LLC","provider_url":"https:\/\/allphasepharma.com\/dir","author_name":"Harald","author_url":"https:\/\/allphasepharma.com\/dir\/author\/haraldeva\/","title":"FDA Adboard on Tedizolid - Why? - Allphase Pharma Consulting, LLC","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"q40i6HtijT\"><a href=\"https:\/\/allphasepharma.com\/dir\/2014\/04\/15\/104\/fda-adboard-on-tedizolid-why\/\">FDA Adboard on Tedizolid &#8211; Why?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/allphasepharma.com\/dir\/2014\/04\/15\/104\/fda-adboard-on-tedizolid-why\/embed\/#?secret=q40i6HtijT\" width=\"600\" height=\"338\" title=\"&#8220;FDA Adboard on Tedizolid &#8211; Why?&#8221; &#8212; Allphase Pharma Consulting, LLC\" data-secret=\"q40i6HtijT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/allphasepharma.com\/dir\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"FDA\u2019s Advisory Board session for tedizolid (3\/31\/2014) was a foregone affair:\u00a0 Looking at the reviewer\u2019s slides, there was really no question about the drug\u2019s efficacy.\u00a0 Did tedizolid cure as many patients as linezolid?\u00a0 Yes, it did.\u00a0 Did the sponsor follow the latest ABSSSI Guidance criteria for establishing non-inferiority?\u00a0 Yes, they Continue reading  &rarr;","thumbnail_url":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2017\/01\/cropped-LLC-Logo-300x125.jpg?fit=245%2C125&ssl=1","thumbnail_width":245,"thumbnail_height":125}